Chemours Company (NYSE: CC) has a price-to-earnings ratio of 53.74x that is above its average ratio. Additionally, the 36-month beta value for CC is 1.72. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 2 rating it as “overweight,” 5 rating it as “hold,” and 0 rating it as “sell.”
The public float for CC is 148.48M and currently, short sellers hold a 8.58% ratio of that float. The average trading volume of CC on May 12, 2025 was 3.30M shares.
CC) stock’s latest price update
Chemours Company (NYSE: CC) has seen a decline in its stock price by -1.60 in relation to its previous close of 11.24. However, the company has experienced a -11.52% decline in its stock price over the last five trading sessions. seekingalpha.com reported 2025-05-07 that The Chemours Company (NYSE:CC ) Q1 2025 Results Conference Call May 7, 2025 8:00 AM ET Company Participants Brandon Ontjes – VP, Investor Relations Denise Dignam – President & Chief Executive Officer Shane Hostetter – Chief Financial Officer Conference Call Participants John McNulty – BMO John Roberts – Mizuho Pete Osterland – Truist Laurence Alexander – Research Analyst Arun Viswanathan – RBC Capital Markets Josh Spector – UBS Duffy Fischer – Goldman Sachs Mike Leithead – Barclays Operator Good morning. My name is Michelle, and I will be your conference operator today.
CC’s Market Performance
Chemours Company (CC) has experienced a -11.52% fall in stock performance for the past week, with a -6.90% drop in the past month, and a -39.43% drop in the past quarter. The volatility ratio for the week is 5.11%, and the volatility levels for the past 30 days are at 5.14% for CC. The simple moving average for the last 20 days is -6.12% for CC stock, with a simple moving average of -36.79% for the last 200 days.
Analysts’ Opinion of CC
Many brokerage firms have already submitted their reports for CC stocks, with Mizuho repeating the rating for CC by listing it as a “Outperform.” The predicted price for CC in the upcoming period, according to Mizuho is $19 based on the research report published on March 27, 2025 of the current year 2025.
Truist, on the other hand, stated in their research note that they expect to see CC reach a price target of $27. The rating they have provided for CC stocks is “Buy” according to the report published on January 28th, 2025.
UBS gave a rating of “Buy” to CC, setting the target price at $30 in the report published on July 09th of the previous year.
CC Trading at -13.16% from the 50-Day Moving Average
After a stumble in the market that brought CC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -62.14% of loss for the given period.
Volatility was left at 5.14%, however, over the last 30 days, the volatility rate increased by 5.11%, as shares surge +2.31% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -27.24% lower at present.
During the last 5 trading sessions, CC fell by -11.52%, which changed the moving average for the period of 200-days by -54.24% in comparison to the 20-day moving average, which settled at $11.78. In addition, Chemours Company saw -34.56% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CC starting from Scarborough Alvenia, who sale 7,500 shares at the price of $20.64 back on Nov 07 ’24. After this action, Scarborough Alvenia now owns 16,645 shares of Chemours Company, valued at $154,771 using the latest closing price.
Scarborough Alvenia, the Officer of Chemours Company, proposed sale 7,500 shares at $20.00 during a trade that took place back on Nov 06 ’24, which means that Scarborough Alvenia is holding shares at $150,000 based on the most recent closing price.
Stock Fundamentals for CC
Current profitability levels for the company are sitting at:
- 0.08 for the present operating margin
- 0.2 for the gross margin
The net margin for Chemours Company stands at 0.02. The total capital return value is set at 0.08. Equity return is now at value 4.66, with 0.40 for asset returns.
Based on Chemours Company (CC), the company’s capital structure generated 0.88 points at debt to capital in total, while cash flow to debt ratio is standing at -0.15. The debt to equity ratio resting at 7.21. The interest coverage ratio of the stock is 1.72.
Currently, EBITDA for the company is 692.0 million with net debt to EBITDA at 5.42. When we switch over and look at the enterprise to sales, we see a ratio of 0.92. The receivables turnover for the company is 7.51for trailing twelve months and the total asset turnover is 0.77. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.75.
Conclusion
In conclusion, Chemours Company (CC) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
